Ventral Hernia Study Using OviTex Reinforced Bioscaffold

NACompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

April 24, 2017

Primary Completion Date

December 8, 2019

Study Completion Date

August 8, 2021

Conditions
Hernia, Ventral
Interventions
DEVICE

OviTex 1S Permanent

OviTex 1S Permanent is a reinforced tissue matrix consisting of layers of extra-cellular matrix derived from sheep stomachs. The layers are embroidered together with a monofilament polypropylene. One side of the mesh has blue polypropylene stitching, which provides a surface conducive to native tissue growth. The other side of the mesh is a smooth surface intended to minimize tissue attachment (adhesions).

Trial Locations (7)

11576

St. Francis Hosptial, Roslyn

34239

Sarasota Memorial Hospital, Sarasota

46202

Indiana University School of Medicine, Indianapolis

66213

St. Luke's Hospital South, Overland Park

73505

Comanche County Memorial Hospital, Lawton

92037

Scripps Clinic, La Jolla

08638

Capital Health, Trenton

All Listed Sponsors
lead

Tela Bio Inc

INDUSTRY

NCT03074474 - Ventral Hernia Study Using OviTex Reinforced Bioscaffold | Biotech Hunter | Biotech Hunter